A group of Vanguard Community Health Centre doctors embarked on a Health System’s Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool , which is now used at Vanguard to detect and prevent renal decline.
All Keywords
【저자키워드】 HIV, South Africa, dolutegravir, renal protection, health system improvement, 【초록키워드】 COVID-19, coronavirus disease, Coronavirus disease 2019, pandemic, protection, renal function, improvement, Antiretroviral therapy, dolutegravir, Patient, ART, community health, regimen, renal, Prevent, detect, facilitated, reducing, commenced, 【제목키워드】 Surveillance, dolutegravir, develop, HIV patient,
【저자키워드】 HIV, South Africa, dolutegravir, renal protection, health system improvement, 【초록키워드】 COVID-19, coronavirus disease, Coronavirus disease 2019, pandemic, protection, renal function, improvement, Antiretroviral therapy, dolutegravir, Patient, ART, community health, regimen, renal, Prevent, detect, facilitated, reducing, commenced, 【제목키워드】 Surveillance, dolutegravir, develop, HIV patient,
Vanguard Community Health Center 의사 그룹은 돌루테그라비르(DTG) 기반 항레트로바이러스 요법(ART) 요법을 시작했거나 전환한 환자의 신장 기능 손상을 줄이기 위한 목적으로 건강 시스템 개선(HSI) 프로젝트에 착수했습니다. 2019년부터 ART 요법 스위치의 일반적인 모니터링 및 평가가 코로나바이러스 질병 2019(COVID-19) 대유행으로 인해 중단되었습니다. 가정의에 의해 촉진된 성찰 과정을 포함하는 이 의도된 위해 감소 운동은 Vanguard 신장 보호 감시 도구의 개발로 이어졌습니다. 이 도구는 현재 Vanguard에서 신장 쇠퇴를 감지하고 예방하는 데 사용됩니다.